课题基金 / 基金详情

BLRD Research Career Scientist Award Application

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
批准号:
10589966
负责人:
Shuk-Mei Ho
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-10-01 至 2027-09-30
关键词:
AccountingAddressAdsorptionAdultAfghanistanAgarAndrogen SuppressionAnimal ModelAnimalsAnniversaryAromatic Polycyclic HydrocarbonsArsenicAwardBarker HypothesisBiological MarkersBody FluidsCanadaCancer PatientCancer Research ProjectCarcinogensCell DeathCell SeparationCellsCensusesChemicalsChildhood AsthmaChronic DiseaseClassificationClinical ResearchCommunitiesDataDatabasesDepartment of DefenseDermalDevelopmentDiagnosticDiseaseDisparityDrug TargetingESR1 geneEducational workshopElderlyEndocrine DisruptorsEndocrine disruptionEnvironmentEnvironmental ExposureEnvironmental HealthEnvironmental and Occupational ExposureEpidemiologyEpigenetic ProcessEpitheliumEstrogen Receptor betaEstrogensEuropean UnionExposure toFundingGPER geneGeneral PopulationGenesGenetic TranscriptionGoalsGonadal Steroid HormonesGrantHealthHigh-Risk CancerHormonal CarcinogenesisHumanImmuneIncidenceInfluentialsInformaticsIngestionInhalationInternationalInternational AgenciesInterventionIonsIraqJointsKidney TransplantationKnowledgeLeadLead levelsLesionLifeLinkMalignant NeoplasmsMalignant neoplasm of prostateMediatingMedical ResearchMetal CarcinogenesisMetal exposureMetalsMethylationMilitary PersonnelMolecularMusNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Toxicology ProgramOccupationalOccupational ExposureOccupationsOhioOilsOncogenicPaperParticipantPeer ReviewPoliciesPopulationProductivityProstateProstatic EpitheliumProtein IsoformsPublishingRefuse DisposalReportingResearchRiskRisk FactorsRoleSafetyScientistSeminalSignal PathwaySmokeSocietiesSourceStrategic PlanningTestingThe Cancer Genome AtlasTherapeuticToxicant exposureToxicologyTranslatingTranslationsTumor Suppressor ProteinsUmbilical Cord BloodUnited StatesUnited States Department of Veterans AffairsUnited States National Institutes of HealthUrineUrologyVeteransVisualizationWomanWorkage groupanticancer researchbisphenol Aburn pitcancer diagnosiscancer stem cellcarcinogenesiscarcinogenicitycareercastration resistant prostate cancerchemical carcinogencomparison controlconsumer behaviordata registrydisabilitydisorder riskearly life exposureenvironmental toxicologyepigenomicsepithelial stem cellexperiencegenetic signaturehazardhigh riskhormone regulationimprovedin vivoindexinginsightlead exposuremalemembermetaplastic cell transformationmilitary servicemilitary veteranmouse modelneoplasm registrynovelnovel strategiesprecision medicinepremalignantpreventprogramspromoterprostate cancer cellprostate cancer modelprostate cancer preventionprostate cancer riskprostate carcinogenesispublic health interventionpublic health researchsingle-cell RNA sequencingspecific biomarkersstem cell biologystem cell populationstem cellsstem-like cellsymposiumtoxicanttranscriptomicstrendunderstudied cancerurinaryurologic

项目摘要

项目成果

Shuk-Mei Ho的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
According to the United States (US) Census Bureau, the number of veterans in the US in 2018 was around 19.9 million. Nine out of 10 were males, and 33% were between 50-69 years old, an age group that is at the highest risk for prostate cancer (PCa). The VA Central Cancer Registry consistently shows that PCa is the most frequently diagnosed cancers among male veterans, accounting for >30% of the approximately 50,000 cancer diagnoses. There is growing concern that environmental and/or occupational exposure to metal ions during deployment and post-deployment increases PCa risk in veterans. The International Agency for Cancer Research classified inorganic arsenic (iAs) as a carcinogen, while lead (Pb) is a potential carcinogen in humans. Pb exposure is a known hazard of military service, while data for iAs exposure is less well-established. Further, wide-spread exposure to these metal ions in veterans could be mediated through inhalation, ingestion, and dermal adsorption of toxic smoke from burning oil fields and waste disposal burn-pits. iAs and/or Pb exposure have been considered potential risk factors for PCa, but the underlying mechanism is largely undefined. In a small clinical study, we found that iAs and Pb levels were significantly higher in the urine of PCa patients compared to controls. Using our new 2-hit animal model, we found that exposure to iAs or Pb increased (1) PCa risk in vivo and (2) the ability of prostate epithelial stem-like cells (PrESLCs) isolated from treated animals to form colonies in soft agar, a hallmark of cellular transformation. In this animal model, a 1-month metal treatment followed by chemical carcinogen treatment significantly increased the incidence of PCa and pre-cancerous lesions in iAs-treated mice, with similar trends in Pb-treated animals. Importantly, single-cell RNAseq analyses revealed that Pb was associated with the expansion of a subpopulation of PrESLCs with epithelial lineage markers into stroma-like oncogenic cells, while iAs was associated with the emergence of a rare, unique subpopulation of oncogenic PrESLCs similar to “cancer” stem cells. This proposal will test the hypothesis that iAs and/or Pb dysregulate specific, and likely different, signaling pathways in subpopulations of PrESLCs to initiate or increase the risk of carcinogenesis in the prostate. This is an untested hypothesis in the field of prostate carcinogenesis and in military veterans’ health. Two Aims are proposed. Aim 1: Determine the carcinogenic potential of metal treated PrESLCs in vivo using a renal grafting model of PCa formation. We will evaluate the effects of metals on the formation of PCa in vivo in immune-deficient host mice, either with or without chemical induction of PCa. Aim 2: Characterize stem-like cells with metal-specific transcriptomic signatures. We will use single-cell RNAseq and visualization informatics to identify the unique gene signatures that characterize rare subpopulations of metal-induced cancer stem cells within the PrESLC population. We aim to apply these gene signatures to enrich rare subpopulations by FACS and evaluate their carcinogenic potential. We will also leverage The Cancer Genome Atlas PCa data and other online databases to enable accurate classification of major, rare, and heterogeneous subtypes of PrESLCs to gain insights into metal carcinogenesis. Findings from the proposed work may address questions related to occupational and post-deployment exposure and expand our knowledge of stem cell biology. Successful completion of these studies may lead to the development of new PCa prevention and therapeutic strategies. Plans to reduce unnecessary exposure to those metal ions can be justified and implemented as effective strategies for PCa prevention. Drugs targeting specific subpopulations of stem cells may be used as therapeutic options to prevent early PCa development and slow progression. When applied to veterans, the results of this study may save lives, improve health, and decrease disabilities in this community and beyond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality
  • 批准号:
    10391233
  • 项目类别:
  • 资助金额:
    $49.52万
  • 财政年份:
    2022
  • 负责人:
    Shuk-Mei Ho
  • 依托单位:
RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality
  • 批准号:
    10615715
  • 项目类别:
  • 资助金额:
    $49.96万
  • 财政年份:
    2022
  • 负责人:
    Shuk-Mei Ho
  • 依托单位:
Metal-induced cell-level changes in prostate epithelium and cancer risk
Metal-induced cell-level changes in prostate epithelium and cancer risk
海外基金